News

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...
A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...
In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.
Discover how a 5-day fasting-mimicking diet revolutionizes type 2 diabetes management, reducing medications and improving ...
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...
Tara Eacobacci had an appointment with her doctor that was devoted exclusively to the topic of health insurance. A major ...
Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...
The cure for diabetes is a life free from daily insulin injections. Based on that criterion, ten out of 12 people (83%) in a new clinical trial were cured of their diabetes one year after receiving an ...
Patients who took a GLP-1 drug fared better than those in a control group at keeping their blood glucose levels in a healthy ...
Ten people have been effectively cured of their type 1 diabetes after a breakthrough infusion of a new treatment on the path ...
A woman with Type 1 diabetes said her diagnosis felt like a "death sentence" — but with a new stem cell therapy, she's now ...
Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...